Skip to main content
NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
NO

Novocure Ltd (NVCR)

NASDAQ • Healthcare

$15.63
-$1.22 (-7.2%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$16.56
Day Range$15.6 - $16.65
Avg. Volume (3M)1.1M
Market Cap$1.8B
52 Week Range
$9.82$21.45
Next EarningsIn 49 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$183.5M100%
Gross Profitminus cost of goods$142.4M78%

In plain terms: out of every $100 in revenue, Novocure Ltd currently loses $9.

Fundamentals & Financials

Revenue (TTM)
$699.1M
Net Income (TTM)
-$148.5M
EPS (TTM)
-$1.3
ROA (TTM)
-18.68%
Current Ratio
2.89
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+46.3%Q1 2026-$0.22
-21.0%Q2 2026-$0.62
+60.8%Q3 2026-$0.13
Next

Oct 29

in 49 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Novocure Ltd

Novocure Ltd is a healthcare company listed on NASDAQ as NVCR that develops, manufactures, and commercializes tumor treating fields (TTFields) devices for solid tumor cancers. Its device portfolio includes Optune Gio, Optune Lua, and Optune Pax, and the business generated $655.4 million in FY2025 revenue.

Name
Novocure Ltd
CEO
Frank Leonard
Website
www.novocure.com
Industry
Healthcare
Year Founded
2000
Employees
1,605

Today's Snapshot

AI-generated

Yesterday NVCR fell 7.2% to 15.63.

Trading Volume

Above 10d avg 973.1K

995.5K

vs S&P 500 Today

Strong Underperformance

-6.76%

Updated: September 10, 2026 at 12:11 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
NVCR's technicals skew bearish with sharply negative momentum readings and prices trading under most short- and medium-term moving averages, even though the 200-day average lies below the current level. CCI shows pronounced downside pressure while RSI remains below neutral, and ATR indicates above-average volatility for the share price. On-balance volume registers sizable activity that the system flags as distribution, and the classic pivot sits noticeably higher than the market. Technical takeaway: the weight of momentum, volatility and moving-average structure supports a sell posture despite a higher 200-day level.
All signals
  • EMA (5 indicators)$14.80 - $17.21
    Sell
  • RSI (14)39.23
    Neutral
  • Stochastic %K (14, 3, 3)31.47
    Neutral
  • MACD Level (12, 26)0.06
    Neutral

Peers & Related Assets

PLSEPulse Biosciences, Inc.
$52.97+8.6%
NEOGNeogen Corporation
$11.92+0.3%
BLFSBioLife Solutions, Inc.
$34.93-1.3%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
AZTAAzenta, Inc.
$30.15-2.2%
STAASTAAR Surgical Company
$23.62-2.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.